Affordable Access

deepdyve-link
Publisher Website

One-year open-label safety evaluation of the fixed combination of ibuprofen and famotidine with a prospective analysis of dyspepsia.

Authors
  • Bello, Alfonso E1
  • Kent, Jeffrey D
  • Grahn, Amy Y
  • Ball, Julie
  • Holt, Robert J
  • 1 University of Illinois-Chicago, College of Medicine, and Illinois Bone and Joint Institute, LLC , Glenview, IL , USA.
Type
Published Article
Journal
Current Medical Research and Opinion
Publisher
Informa UK (Librapharm)
Publication Date
Mar 01, 2015
Volume
31
Issue
3
Pages
397–405
Identifiers
DOI: 10.1185/03007995.2014.999152
PMID: 25495134
Source
Medline
Keywords
License
Unknown

Abstract

These data, together with previously reported findings of a significant decrease in upper gastrointestinal endoscopic ulcer rate at 6 months, support the overall safety, compliance, and tolerability of this single-tablet formulation.

Report this publication

Statistics

Seen <100 times